Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
A GNAS1 imprinting defect in pseudohypoparathyroidism type IB
Jie Liu, … , Leslie G. Biesecker, Lee S. Weinstein
Jie Liu, … , Leslie G. Biesecker, Lee S. Weinstein
Published November 1, 2000
Citation Information: J Clin Invest. 2000;106(9):1167-1174. https://doi.org/10.1172/JCI10431.
View: Text | PDF
Article

A GNAS1 imprinting defect in pseudohypoparathyroidism type IB

  • Text
  • PDF
Abstract

Pseudohypoparathyroidism type IB (PHPIB) is characterized by renal resistance to parathyroid hormone (PTH) and the absence of other endocrine or physical abnormalities. Familial PHPIB has been mapped to 20q13, near GNAS1, which encodes Gsα, the G protein α-subunit required for receptor-stimulated cAMP generation. However, Gsα function is normal in blood cells from PHPIB patients, ruling out mutations within the Gsα coding region. In mice Gsα is expressed only from the maternal allele in renal proximal tubules (the site of PTH action) but is biallelically expressed in most other tissues. Studies in patients with Albright hereditary osteodystrophy suggest a similar Gsα imprinting pattern in humans. Here we identify a region upstream of the Gsα promoter that is normally methylated on the maternal allele and unmethylated on the paternal allele, but that is unmethylated on both alleles in all 13 PHPIB patients studied. Within this region is an alternative promoter and first exon (exon 1A), generating transcripts that are normally expressed only from the paternal allele, but that are biallelically expressed in PHPIB patients. Therefore, PHPIB is associated with a paternal-specific imprinting pattern of the exon 1A region on both alleles, which may lead to decreased Gsα expression in renal proximal tubules. We propose that loss of exon 1A imprinting is the cause of PHPIB.

Authors

Jie Liu, Deborah Litman, Marjorie J. Rosenberg, Shuhua Yu, Leslie G. Biesecker, Lee S. Weinstein

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Methylation analysis of GNAS1. (a) The normal allele-specific methylatio...
Methylation analysis of GNAS1. (a) The normal allele-specific methylation and expression patterns of the four known first exons of GNAS1, which splice onto exon 2 to produce transcripts encoding NESP55, XLαs, a transcript of unknown function (exon 1A), and Gsα (exon 1). Horizontal arrows indicate transcriptionally active promoters. The imprinting of NESP55 and XLαs have been defined previously (8, 9, 11). Exon 1 is probably paternally imprinted in some tissues, indicated by the dashed arrow. NESP55 protein is unrelated to Gsα, and its entire coding region is located within its first exon. In contrast, XLαs and Gsα proteins have identical COOH-terminal domains (encoded by exons 2–13), while their unique NH2-terminal domains are encoded within their respective first exons. Exon 1A does not have a translational start site, and its transcripts are likely to be untranslated. The imprinting of the exon 1A region has been defined previously in mice (10). (b) Southern analyses of leukocyte genomic DNA from a normal subject (N), PHPIB patients 1, 3, and 7, the mother of patient 1 (1M), and the father of patient 1 (1F), using genomic DNA probes from the NESP55 (left panel; ref. 9), XLαs (middle panel; ref. 8), and exon 1A (right panel) regions. Above are the relevant restriction maps depicting each upstream exon as a black box and the position of the probes below. Patient 1 is abnormally methylated in all three regions, patient 3 is abnormally methylated only in the exon 1A region, and patient 7 is abnormally methylated in the NESP55 and exon 1A, but not the XLαs, regions. Bg, BglII; S, SacII; F, FspI, N, NgoMIV; A, AscI; Bs, BssHII; P, PstI; Mat, maternal allele; Pat, paternal allele.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts